Filing Flows › Neuronetics (STIM) › Q1 2025
Neuronetics (STIM) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 6, 2025
Neuronetics (STIM) reported revenue of $32.0M for the first quarter 2025 (Q1 2025), +84% from a year earlier and +84% from the quarter before. Operating margin was -34.4%, net loss $12.7M (39.7% of revenue).
Neuronetics, Q1 2025: revenue $32.0M (+84% year over year), operating margin -34.4%, net loss $12.7M, operating cash flow −$17.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.0M | +84% | +84% |
| Operating profit | −$11.0M | — | — |
| Net earnings | −$12.7M | — | — |
| Operating cash flow | −$17.0M | — | — |
What changed
Revenue was $32.0M in Q1 2025, up 84% year over year and up 84% from the previous quarter.
Gross margin was 49.2%, down 25.9 points from a year earlier. Operating costs exceeded revenue by $11.0M, an operating margin of -34.4%. Operating expenses grew 34% against revenue growth of 84%. The fastest-growing cost line was General & admin (+121%). The quarter ended with a net loss of $12.7M, wider than the previous quarter's $3.9M loss.
Operating cash flow was −$17.0M. Non-cash charges added back $911K of depreciation and amortization and $1.4M of share-based compensation. Working capital and other items used $6.7M. Capital expenditures of $219K exceeded it, leaving free cash flow of −$17.2M.
Questions
What was Neuronetics' revenue in the first quarter 2025?
Neuronetics (STIM) reported revenue of $32.0M for the first quarter 2025 (Q1 2025), +84% from a year earlier and +84% from the quarter before.
Was Neuronetics profitable in the first quarter 2025?
Operating loss was $11.0M (-34.4% of revenue) and net loss $12.7M.
Source: Neuronetics 10-Q on SEC EDGAR.